AUS
NZ
UK
CA
USA
IND
Healt
Orthocell signs up first four Remplir distributors in the lucrative US market
April 23, 2025 02:08 PM AEST| By Team Kalkine MediaHighlights:,Orthocell appoints four US distributors following recent regulatory approval of its Remplir product.,The company is pursuing broader geographic representation through an expanding distributor network.,Remplir is already available in sever...
Race Oncology Progresses RC220 Clinical Trial and Enhances Profile
April 23, 2025 02:05 PM AEST| By Team Kalkine MediaHighlights:,Race Oncology received ethics and regulatory clearance to initiate its Phase 1 RC220 trial.,Clinical activity began at Southside Cancer Care Centre, with additional trial sites preparing for activation.,The company maintained a robust fin...
Orthocell Taps into Lucrative US Market with Strategic Distributor Rollout for Remplir
April 23, 2025 01:35 PM AEST| By Team Kalkine MediaHighlights,Orthocell expands into the US nerve repair market with four initial distributors,Remplir rollout supported by inventory and efficient distribution model,Targeting further expansion to reach 25 US states by mid-year,Regenerative medicine sp...
Race Oncology Progresses Cancer Drug Trial and Strengthens Financial Footing in March Quarter
April 23, 2025 01:18 PM AEST| By Team Kalkine MediaHighlights,Phase 1 trial for RC220 gains key regulatory approvals,Strong cash reserves to support over two years of operations,Inclusion in All Ordinaries Index underscores market recognition,Race Oncology (ASX:RAC) marked significant progress during...
Why Sonic Healthcare (ASX:SHL) Remains a Standout in a Shifting Market
April 23, 2025 12:10 PM AEST| By Team Kalkine MediaHighlights,SHL shares down 8.5% in 2025 despite long-term growth prospects,Healthcare sector offers stable, recession-resistant revenue streams,Global trends position SHL for sustainable and ethical-focused growth,The share price of Sonic Healthcare...
Orthocell anticipates imminent US Remplir sales after securing a distribution agreement.
April 23, 2025 11:30 AM AEST| By Team Kalkine MediaHighlights,Orthocell expands into U.S. with strategic product distribution agreement,Remplir targets critical need in surgical nerve repair market,Strong financial position supports international growth strategy,The biotechnology sector is currently...
Ansell Delivers 13% Return Over the Year Despite Recent Weakness
April 23, 2025 11:11 AM AEST| By Team Kalkine MediaHighlights,Ansell (ANN) posted a 13% return over the past year,Share price dipped 17% in the last quarter, contrasting long-term gains,Revenue growth and dividends supported positive total returns,Ansell (ASX:ANN) has offered investors a noteworthy r...
Alcidion Group Advances on Market Despite Revenue Decline
April 22, 2025 09:02 PM AEST| By Team Kalkine MediaHighlights,Alcidion Group operates in the health technology sector with a focus on digital healthcare solutions,The company experienced a significant increase in share price over the past year despite a decline in revenue,Longer-term performance rema...
Telix Pharmaceuticals (ASX:TLX) Delivers Strong Q1 Growth with Revenue Surge and Strategic U.S. Expansion
April 22, 2025 07:32 PM AEST| By Team Kalkine MediaHighlights,Telix revenue jumps 62% YoY to $186 million in Q1 2025,Illuccix® sales power growth with $151 million contribution,Strategic RLS acquisition adds $33 million and expands U.S. operations,Telix Pharmaceuticals (ASX:TLX) has kicked off FY 202...
Oversold ASX Healthcare Share Sees Major Drop Despite Strong Business Momentum
April 22, 2025 04:11 PM AEST| By Team Kalkine MediaHighlights:,Healthcare software firm sees significant drop from its yearly peak amid broader tech sector decline,Business maintains strong margins, debt-free status, and continues securing large US contracts,Strategic expansion in artificial intellig...
Recce Expands R327G Foot Gel Trial with Addition of 20 Participants
April 22, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals expands its Phase II trial for R327G topical gel with additional participants,Promising clinical responses reported, meeting primary endpoints in diabetic foot infection treatment,Data supports advancement towards reg...
Key Metrics to Evaluate Pro Medicus Ltd (ASX: PME) within the ASX Healthcare Stocks Sector
April 22, 2025 02:53 PM AEST| By Team Kalkine MediaHighlights:,Pro Medicus Ltd (ASX:PME) operates in the healthcare software sector, offering advanced radiology IT solutions globally.,Core metrics such as revenue, gross margin, and profit help assess the company’s financial performance.,The strong fi...
Recce Pharmaceuticals Advances Diabetic Foot Infection Trial, Strengthening ASX Healthcare Stocks Presence
April 22, 2025 02:35 PM AEST| By Team Kalkine MediaHighlights:,Recce Pharmaceuticals receives ethics approval to expand its Phase 2 diabetic foot infection trial.,The therapeutic R327G continues development with additional patients and new data pathways.,Broader efforts in Australia and Indonesia sup...
Mayne Pharma Delivers Strong Earnings Growth Despite Quarterly Headwinds
April 22, 2025 11:51 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma earnings surged 116% year-to-date,Quarterly sales dip due to weaker dermatology performance,Acquisition by Cosette expected to close this year,Mayne Pharma (ASX:MYX) has reported a substantial earnings rise of 116% for the fin...
Race Oncology Expands RC220 Cancer Trial to Second Australian Site
April 22, 2025 10:41 AM AEST| By Team Kalkine MediaHighlights,RC220 clinical trial opens second site in Australia,Phase 1 aims to assess safety, dosage, and efficacy,Trial includes multiple global locations,Race Oncology (ASX:RAC) has expanded its ongoing Phase 1 clinical trial for RC220, a next-gene...
AI-Powered Health Tech Boosts Women’s Health in Vietnam with TruScreen’s New Screening Initiative
April 22, 2025 10:37 AM AEST| By Team Kalkine MediaHighlights,TruScreen,Group,initiates,a five-year AI-enabled cervical cancer screening drive in Vietnam.,260,000 women to be screened across Ho Chi Minh City under public-private collaboration.,TruScreen,Ultra offers real-time, non-invasive results wi...
Insider Transactions at HITIQ Limited (ASX:HIQ): An Overview
April 21, 2025 02:30 PM AEST| By Team Kalkine MediaHighlights,Insiders have sold more shares than they purchased in HITIQ Limited (HIQ) over the past year.,Otto Buttula made the largest insider sale, significantly above the current market price.,Insiders hold 19% of HITIQ shares, indicating alignment...
Can This ASX Healthcare Stock Sustain Its Momentum on the S&P/ASX 200 and All Ordinaries Indexes?
April 19, 2025 08:30 AM AEST| By Team Kalkine MediaHighlights,The company operates in the healthcare sector and is listed on both the S&P/ASX 200 and All Ordinaries indexes.,Cash expenditure has declined, enhancing its ability to maintain operations over the medium term.,Revenue growth has coincided...
Is ResMed CDI (ASX:RMD) Share Price Undervalued in 2025? Six Metrics That Matter
April 17, 2025 08:36 PM AEST| By Team Kalkine MediaHighlights:,ResMed operates in the medical equipment sector with a global footprint,The company specialises in CPAP systems and healthcare-focused software,Share price has declined since the start of the year,ResMed CDI (ASX:RMD) operates in the medi...
Imricor (ASX:IMR) Gains European Regulatory Nod for Entire Product Line, Readies EU Launch
April 17, 2025 05:42 PM AEST| By Team Kalkine MediaHighlights,Imricor receives CE Mark under new EU regulations,Launch planned in June across Europe,Entire commercial portfolio now MDR-certified,Imricor Medical Systems (ASX:IMR),has secured a significant milestone with the CE Mark approval of its Adv...
Advertise your brand on Kalkine Media